eBioscience Acquired By Affymetrix

San Diego-based eBioscience, a developer of flow cytometry and immunoassay reagents for immunology and oncology research and diagnostics, is being acquired by Affymetrix, Affymetrix said Wednesday. Affymetrix said it is paying $330M in cash to acquire eBioscience, in a deal that is expected to close late in Q4 of 2011. eBioscience was founded in 1999. Affymetrix said that it expects 2011 sales from eBioScience to exceed $70M.